All Stories

  1. Preventing bisphosphonate induced osteonecrosis of the jaw with a polyguanidine conjugate (GuaDex): A promising new approach

    Article • Bone, October 2024, Elsevier

    Marcela Márquez-Holmberg

  2. The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages

    Article • Investigational New Drugs, March 2024, Springer Science + Business Media

    Marcela Márquez-Holmberg

  3. Cytotoxicity of poly-guanidine in medulloblastoma cell lines

    Article • Investigational New Drugs, August 2023, Springer Science + Business Media

    Marcela Márquez-Holmberg

  4. Poly-guanidine shows high cytotoxicity in glioma cell cultures and glioma stem cells

    Article • Investigational New Drugs, March 2022, Springer Science + Business Media

    Marcela Márquez-Holmberg

  5. Antimicrobial Activity of a Cationic Guanidine Compound against Two Pathogenic Oral Bacteria

    Article • International Journal of Microbiology, January 2017, Hindawi Publishing Corporation

    Myriam Angélica De La Garza-Ramos, Marcela Márquez-Holmberg, Erandi Escamilla-García

  6. Biodistribution, Blood Half-Life, and Receptor Binding of a Somatostatin-Dextran Conjugate

    Article • Medical Oncology, January 2001, Springer Science + Business Media

    Marcela Márquez-Holmberg

  7. The potential of radiolabeled EGF‐dextran conjugates in the treatment of urinary bladder carcinoma

    Article • Cancer, December 1997, Wiley

    Marcela Márquez-Holmberg

  8. 99MTc-Dextran-Antibody Conjugates : Labelling procedures

    Article • Acta Oncologica, January 1996, Acta Dermato-Venereologica

    Marcela Márquez-Holmberg

  9. Purification of carboxypeptidase B by metal chelation affinity chromatography

    Article • Journal of Biochemical and Biophysical Methods, January 1992, Elsevier

    Marcela Márquez-Holmberg